NCT02067988View on ClinicalTrials.gov

Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Neuroendocrine Tumors
Interventions
DEVICE

Holmium-166 microspheres hepatic radioembolization.

Holmium-166 microspheres hepatic radioembolization.

Trial Locations (1)

3584 CX

University Medical Center Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT02067988 - Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study | Biotech Hunter | Biotech Hunter